top
Search terms
Results 11 - 20 of 110 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 11
Ejhf

[...]clinical trials of ‘anti-inflammatory’ therapies (such as anti-tumor necrosis factor-α approaches) have to date failed to show benefit in heart failure patients. The Heart Failure ...

European Journal of Heart Failure, Heymans, Stephane, Hirsch, Emilio, Anker, Stefan D., Aukrust, Pal, Balligand, Jean‐Luc, Cohen‐Tervaert, Jan W., Drexler, Helmut, Filippatos, Gerasimos, Felix, ...

Date : 01/02/2009 Item size : 354817 bytes
Eurointervention

If imaging is the eyes of the Heart Team as Nicolo Piazza has so eloquently stated, then innovation is its most intimate dream the waking dream of the interventionalist and clinician as they face the ...

Date : 10/06/2016 Item size : 49140 bytes
Ehjcardioimaging

EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)—EURObservational Research Program of the European ...

Eur Heart J Cardiovasc Imaging, REVIEW ARTICLES, Patrizio Lancellotti, Stefan D. Anker, Erwan Donal, Thor Edvardsen, Bogdan A. Popescu, Dimitrios Farmakis, Gerasimos Filippatos, Gilbert Habib, Aldo ...

Date : 01/05/2015 Item size : 270764 bytes
Ehjournal

CardioPulse ArticlesObituaryFarewell to Professor Henry Krum MDPioneers in cardiovascular medicineMilton Packer MDThe Fifth National Heart Failure Societies' Presidents' SummitThe Postgraduate Course ...

European Heart Journal, CardioPulse

Date : 01/06/2016 Item size : 168102 bytes
Ehjournal

CardioPulse ArticlesHotlines in the European Heart Journal: new and novel featuresA management algorithm for acute heart failure in pregnancyDetecting and managing cardiovascular disease during ...

European Heart Journal, CardioPulse

Date : 01/04/2015 Item size : 154271 bytes
Epeuropace

[...]we compared atrial antitachycardia pacing (ATP) therapy and combined atrial ATP and atrial pace prevention (ATP + Prevention) algorithms to conventional DDD/R pacing for prevention of AT/AF over ...

Europace, Anne M. Gillis, Margaret Morck, Derek V. Exner, Robert S. Sheldon, Henry J. Duff, Brent L. Mitchell, George D. Wyse

Date : 01/08/2009 Item size : 245281 bytes
Epeuropace

Currently, it is recognized that there is a sustained reduction in new-onset AF in patients with significant underlying heart disease (e.g. left ventricular dysfunction and hypertrophy) treated with ...

Europace, Editorial, Laurent Fauchier, Pascal de Groote

Date : 01/03/2011 Item size : 145656 bytes
Ehjcardiovascrec

Angiogenic gene therapy for heart disease: a review of animal studies and clinical trials Abstract The current published clinical literature on angiogenic gene therapy for the treatment of ...

Cardiovascular Research, Review, H.Kirk Hammond, M.Dan McKirnan

Date : 16/02/2001 Item size : 206864 bytes
Ejhf

The prevalence of heart failure (HF) increases with age, with the highest rates occurring in those aged >80 years.1 Older patients also have higher hospitalization rates, longer length of hospital ...

European Journal of Heart Failure, Filippatos, Gerasimos, Parissis, John T.

Date : 01/05/2011 Item size : 124449 bytes
Ehjournal

[...]cells that adhere onto tissue culture plastic in serum-containing growth medium and have adipogenic, osteogenic, and chondrogenic differentiation potential in culture were termed mesenchymal ...

European Heart Journal, CURRENT OPINION, Rosalinda Madonna, Linda W. Van Laake, Sean M. Davidson, Felix B. Engel, Derek J. Hausenloy, Sandrine Lecour, Jonathan Leor, Cinzia Perrino, Rainer Schulz, ...

Date : 14/06/2016